| Term 
 
        | Parkinsonism causes and S/Ss |  | Definition 
 
        |   
Parkinsonism includes tremors, rigidity, slow movement (bradykinesia), slurred speech, maskface, difficulty chewing/swallowing; unsteady gait with upper body bent forwardOther conditions beside Parkinson’s disease can cause, though PD most commonDrug adverse reactions can cuase parkinsonism reactions = extrapyramidal symptoms |  | 
        |  | 
        
        | Term 
 
        | levodopa levodopa with carbidopa  amantadine  bromocriptine   rasaglinine  selegiline |  | Definition 
 
        | dopaminergic drugs (increase dopamine in CNS)   rasaglinine and selegiline are MAOI dopaminergics (dopamine agonists) |  | 
        |  | 
        
        | Term 
 
        | Actions of dopaminergic drugs |  | Definition 
 
        |   a.        Increase dopamine (Parkinson's decrease in dopamine) b.       Only crosses B-B Barrier in small amounts c.        Carbidopa is only used with levodopa to increase levodopa absorption (no affect on own carbidopa) d.       levodopa is converted into dopamine e.        others work various mechanisms |  | 
        |  | 
        
        | Term 
 
        | Treatment and route ofr restless leg syndrome |  | Definition 
 
        | dopamine receptor agonists (other) taken transdermally, not oral |  | 
        |  | 
        
        | Term 
 
        | Uses of dopiminergic drugs |  | Definition 
 
        |   a.        parkinson's b.       Extrapyramidal symptoms (parkinson's like) c.        Restless leg syndrome d.       viral infections |  | 
        |  | 
        
        | Term 
 
        | Adverse reactions to levodopa (and any levodpa combinations) |  | Definition 
 
        | 
levodapa/carbidopa effect decreases over timedry mouth, difficulty swallowingab pain constipationincreased hand tremorheadache and dizzinessMost serious with levodapa are CHOREIFORM MOVEMENTSLess common are mental changes like dementia, depression, psychotic episodes, paranoia, suicidal tendencies     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
  invol twitching of limbs or facial muscles, dystonic movements (spasms of tongue, jaw, eyes, neck usually)can be caused by levodopa/carbidopa adminIf occurs, withhold and notify immediately |  | 
        |  | 
        
        | Term 
 
        | Contraindications levodopa (and any levodopa combinations) |  | Definition 
 
        |                                                                  i.      narrow-angle glaucoma                                                               ii.      MAOIs                                                             iii.      can activate malignant melanoma |  | 
        |  | 
        
        | Term 
 
        | contraindications of MAOI dopamine agoists |  | Definition 
 
        |                                                                  i.      opioid meperidine (Demerol) bc of antimetabolite conversion |  | 
        |  | 
        
        | Term 
 
        | Precautions levodopa (or any levodopa combination) |  | Definition 
 
        | 
CV or pulm diseasepeptic ulcersrenal or hepatic diseasepsychosis pregnancy and lactation (cat C) |  | 
        |  | 
        
        | Term 
 
        | Precautions MAOI dopamine agonists |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 1.        benztropine 2.        biperiden 3.        diphenhydramine 4.        procyclidine 5.        trihexyphenidyl |  | Definition 
 
        | 
cholinergic blocking (anticholinergic) drugs for treatment of parkinsonism are used for other conditions as well |  | 
        |  | 
        
        | Term 
 
        | Actions/uses of anticholinergics for tx of parkinsonism |  | Definition 
 
        | 
ACh is increased in Parkinson's, so drugs are used to block this to enhance dopamine transmissionless effective than levodopadosage limited by adverse reactions - diphenhydramine has least effects, best for elderly
 
adjunct to all forms of parkinsonismcontrol drug induced extrapyramidal effects
 |  | 
        |  | 
        
        | Term 
 
        | Adverse reactions to anticholinergics |  | Definition 
 
        | 
dry mouthblurred visiondizzinessmild nauseanervousnessrash, urticariaurinary retention, dysuriatachycardiamuscle weaknessdisorientation, confusion>60 often have sensitivity to anticholinergics, require close monitor, esp. confusion and disorientation; may need lower doses
 |  | 
        |  | 
        
        | Term 
 
        | Contraindications of anticholinergics |  | Definition 
 
        | 
angle-closure glaucomapyloric or duodenal obstructionpeptic ulcersprostate hypertrophyachalasia (difficulty swallowing from lower esoph. muscles not relaxing)myesthenia gravismegacolon
 |  | 
        |  | 
        
        | Term 
 
        | Precautions of anticholinergics |  | Definition 
 
        | 
tachydardiacardiac arrhythmiashyper/hypo tensiontendency towards urinary retentiondecreased liver or kidney functionobstructive disease of GI tractolder adults
 Remember that anticholinergics are drying, which can reduce blood volume.  This can increase heart rate to compensate.  Therefore, caution with existing tachycardia, arrythmias, BP issues, inability to pee, kidneys/liver preexisting problem and need blood flow, GI stasis AND OLDER ADULTS MORE SENSATIVE TO ALL |  | 
        |  | 
        
        | Term 
 
        | 1.        entacapone 2.        tolcapone |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Action and Uses of COMT inhibitors |  | Definition 
 
        | 
prolong effect of levodopa by bloching the enzyme COMT (normally eliminates dopamine)increase plasma concentration and duration of action levodopa
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
adjunct to levodopa/carbidopa for Parkinson'sTolcapone reserves for those not responding to other treatments bc very hepatotoxicEntacapone less stong than tolcapone
 |  | 
        |  | 
        
        | Term 
 
        | Adverse reactions to COMT inhibitors |  | Definition 
 
        | 
dizzinessdyskinesias, hyperkinesiasnausea, anorexia, diarrheaorth hyposleep disoreders, excessive dreaming, somnolencemuscle crampsliver failure and death with tolcapone
 |  | 
        |  | 
        
        | Term 
 
        | Contraindications of COMT inhibitors |  | Definition 
 
        | 
pregnancy and lactation (cat C)Tolcapone contra in those with liver dysfunction
 |  | 
        |  | 
        
        | Term 
 
        | Precautions of COMT inhibitors |  | Definition 
 
        | 
hyper/hypo tensiondecreased renal and hepatic function (except tolcapone contraindication liver dysfunction)
 |  | 
        |  | 
        
        | Term 
 
        | 1.        apomorphine 2.        pramipexole 3.        ropinirole |  | Definition 
 
        | 
Non-ergot dopamine receptor agonistsNot derived from ergot, which is a fungusEarly dopamine agonists were ergot-derived (are not included in book)     |  | 
        |  | 
        
        | Term 
 
        | Actions of the non-ergot dopamine receptor agonists |  | Definition 
 
        | 
not understoodthought to act on postsynaptic dopamine receptors in brain, mimicking effect of dopamine
 |  | 
        |  | 
        
        | Term 
 
        | Uses of the non-ergot dopamine receptor agonists |  | Definition 
 
        | 
Parkinson'sapomorphine is used for "on-off" phenomenon and must be given with an antiemetic
 |  | 
        |  | 
        
        | Term 
 
        | Adverse reactions of the non-ergot dopamine receptor agonists |  | Definition 
 
        | 
pramipexole and ropinirole (apomorphine not included)N/V, dizzinessInsomniasomnolence, hallucinations, confusion, visual disturbancespostural hypotensionabnormal involuntary movements headachedyspepsia 
 |  | 
        |  | 
        
        | Term 
 
        | Contraindications of the non-ergot dopamine receptor agonists |  | Definition 
 
        | 
safety not established for pregnancy (cat C)
 |  | 
        |  | 
        
        | Term 
 
        | Precautions of the non-ergot dopamine receptor agonists |  | Definition 
 
        | 
dyskinesiaortho hypohepatic or renal impairmentCV diseasehx hallucinations or psychosis
 |  | 
        |  | 
        
        | Term 
 
        | Preassessment for admin of antiparkinsonism drug |  | Definition 
 
        | a.        Hx may be hard to obtain from Parkinson pt bc of mental changes; may question family member, etc b.       Assess symptoms, how long sxs, ADL ability, mental condition (memory, depression, withdrawal, etc.) c.        Physical assessment for baseline d.       Eval neuromuscular status, e.g. tremors, mask-face, gait, speech, etc |  | 
        |  | 
        
        | Term 
 
        | Ongoing assessment of antiparkinsonism drug |  | Definition 
 
        | a.        Observe neuromuscular status to evaluate response t odrug b.       Improvement may be slow |  | 
        |  | 
        
        | Term 
 
        | antiparkinsonism drugs and dosage titration |  | Definition 
 
        | a.        Optimal response requires adjustments/titration, explain this to pt and family; Report all adverse reactions to help with dosage adjustments |  | 
        |  | 
        
        | Term 
 
        | Mental changes and antiparkinsonism drug given for extrapyramidal adverse reactions of other drugs |  | Definition 
 
        | a.        When given to manages adverse reactions to other drugs, antiparkinsonism drugs may worsen mental sxs leading to psychotic event – observe pt’s behavior frequently – if sudden behavioral change, withhold and immediately notify PCP |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
  NURSING ALERT – tolcapone (Tasmar) can cause fatal hepatotoxicity.Usually prescribed regular hepatic fnx tests including serum aminotransferase q 2 weeks for first year, and q 8 weeks afterwards. Tx DC if aminotransferase is high OR S/S of hepatic failure:observe for persistent nausea, fatigue/lethargy, anorexia, jaundice, dark urine, pruritus and RUQ tenderness. |  | 
        |  | 
        
        | Term 
 
        | Carbidopa/levodopa and choreiform movements |  | Definition 
 
        | a.        for carbidopa/levodopa admin, watch for CHOREIFORM and dystonic movements such as facial grimacing, protruding tongue, exaggerated chewing, jerking of extremities.  If these occur, withhold dose and immediately notify PCP bc drug may need reduction of DC. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
ON-OFF PHENOMENON can occur with LEVODOPA.  Sudden change from improvement to loss of tx effect. Associated with long term levodopa use. Sometimes, PCP orders a “drug holiday,” where pt is completely w/drawn from levodopa for 5-14 days and gradually restarted at lower doseMust monitor for COMPLICATIONS OF LEVODOPA WITHDRAWAL, which can be severe   |  | 
        |  | 
        
        | Term 
 
        | COMPLICATIONS OF LEVODOPA WITHDRAWAL |  | Definition 
 
        | a.        AbruptDC of antiparkinsonism drugs is bad.  Can cause a “neuroleptic malignant-like syndrome,” including (watch for) muscle rigidity, high temp, mental changes. |  | 
        |  | 
        
        | Term 
 
        | Re: antiparkinsonism drug admin: “Imbalanced Nutrition: Less Than Body Requirements rt nausea, dry mouth" |  | Definition 
 
        | a.        Help with dry mouth by suggesting sipping water, ice, hard candy if allowed.   b.       If very severe dry mouth w/ difficulty swallowing or speaking, or if loss of appetite, dosage may need reduction (so report to PCP) c.        Some have N/V and/or constipation which can affect nutrition.  So, small frequent meals, caml environment, and serve preferred food to help eat.  Also weigh daily.  Sometimes helped by giving med with food. d.       Severe N/V may require DC or changing drug, although nausea usually decreases or resolves over time |  | 
        |  | 
        
        | Term 
 
        | Re: antiparkinsonism drug admin:  “Risk for Injury rt dizziness, lightheadedness, orthostatic hypotension, loss of balance” |  | Definition 
 
        | a.        Parkinson’s alone caused problems with ambulation; with drugs can exacerbate: b.       Antipark. drugs may cause blurry vision and diplopia (double vision) c.        Report evidence of visual disturbance to PCP (pt may not verbalize problem) d.       Also watch for sudden behavioral changes and report – hallucinations, depression, psychotic episodes e.        Hallucinations more common with elderly taking antipark. drugs, esp. dopamine receptor agonists.  Assess older adults for hallucinations f.         Adverse reactions of dizziness, muscle weakness and ataxia can worsen ambulation difficulty g.       Parkinson pts prone to falls, good to help ambulate and encourage assistive devices like cane or walker, gripping shoes, good lighting, no throw rugs – carefully assess environment for obstacles, etc. h.       Ortho hyp may result from drug tx – instruct accordingly (rise slowly, etc) |  | 
        |  | 
        
        | Term 
 
        | Education re: antiparkinsonism drug admin |  | Definition 
 
        | a.        evaluate pt’s understanding regimen, self-care ability, ability to comply.  If needs assistance, refer to social worker. b.       Home environment should be set up to reduce likelihood of falling, e.g no throw rugs, hand rails,etc. c.        For GI upset, take with food. d.       Avoid hazardous tasks w/ dizziness, drowsiness, vision problems, etc e.        Avoid alcohol unless approved f.         If dry mouth interferes with dentures, consult dentist g.       Ortho hypo teaching h.       Dry mouth teaching i.         When to notify PCP                                                                i.      severe dry mouth                                                               ii.      inability to chew or swallow                                                             iii.      can’t urinate                                                             iv.      depression, mood alterations                                                              v.      severe dizziness                                                             vi.      rapid or irregular heartbeat                                                           vii.      ab pain                                                          viii.      unusual movements                                                               ix.      For levodopa, avoid B6 (pyridoxine) bc can interfere with action                                                               x.      For diabetics taking levodopa, levodopa can cause inaccurate glucose and ketone testing, first report abnormal result to PCP (don’t alter doses of antidiabetic) j.         For talcapone, especially important to keep appointments to test liver frequently; report any signs of liver failure, including persistent nausea, fatigue/lethargy, anorexia, jaundice, dark urine, pruritus and RUQ tenderness. |  | 
        |  | 
        
        | Term 
 
        | Levodopa and diabetes testing |  | Definition 
 
        | For diabetics taking levodopa, levodopa can cause inaccurate glucose and ketone testing, first report abnormal result to PCP (don’t alter doses of antidiabetic) |  | 
        |  | 
        
        | Term 
 
        | What drugs are included in the one combo antiparkinsonism drug listed?  And what is it's trade name? |  | Definition 
 
        | levodopa + carbidopa + entacapine = Stalevo |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COMT inhibitor portion is entacapone, precautions are: 
tachydardiacardiac arrhythmiashyper/hypo tensiontendency towards urinary retentiondecreased liver or kidney functionobstructive disease of GI tractolder adults dopaminergic portion is levodopa, precautions are 
cv diseasepulmonary diseasepeptic ulcerrenal or hepatic diseasepsychosispregnancy and lactation (cat C) |  | 
        |  | 
        
        | Term 
 
        | Action and use of carbidopa |  | Definition 
 
        | Carbidopa has no effect alone It is given with levodopa to increase amount of levodopa that reaches the brain Levodopa alone doesn't cross BB barrier easily, and stays in periphery with adverse reactions Carbidopa helps levodopa get to brain, therefore reducing dose of levodopa |  | 
        |  | 
        
        | Term 
 
        | Source of levodopa and action in the body? |  | Definition 
 
        | plant and animal derived converted into dopamine in body only small amount cross BB barrier (carbidopa increases this) |  | 
        |  | 
        
        | Term 
 
        | ACHALASIA With drug is contraindicated with this condition? |  | Definition 
 
        | 
difficulty swallowing from lower esoph. muscles not relaxinganticholinergics are contraindicated in those with achalasia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 for carbidopa/levodopa admin, watch for CHOREIFORM and dystonic movements such as facial grimacing, protruding tongue, exaggerated chewing, jerking of extremities.  If these occur, withhold dose and immediately notify PCP bc drug may need reduction of DC.ABNORMAL MOVEMENTS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | a.        Sometimes, PCP orders a “drug holiday,” where pt is completely w/drawn from levodopa for 5-14 days and gradually restarted at lower dose – MUST MONITOR FOR COMPLICATIONS: b.       NURSING ALERT – AbruptDC of antiparkinsonism drugs is bad.  Can cause a “neuroleptic malignant-like syndrome,” including (watch for) muscle rigidity, high temp, mental changes. |  | 
        |  | 
        
        | Term 
 
        | What to watch for if levodopa discontinued? |  | Definition 
 
        | Abrupt DC of antiparkinsonism drugs is bad.  Can cause a “neuroleptic malignant-like syndrome,” including (watch for) muscle rigidity, high temp, mental changes. |  | 
        |  | 
        
        | Term 
 
        | What type of drug is tolcapone? |  | Definition 
 
        | A COMT inhibitor antiparkinsonism drug |  | 
        |  | 
        
        | Term 
 
        | Drug that is used to control "on-off" phenomenon? |  | Definition 
 
        | apomorphine (Apokyn) a dopamine receptor agonist |  | 
        |  | 
        
        | Term 
 
        | levodopa and pyridoxine (B6) |  | Definition 
 
        | pyridoxine (B6) decreases effect of levodopa Does not effect ACTION of levodopa if given with carbidopa) B6 sometimes prescribed to lessen adv rxns (not action?) of levodopa |  | 
        |  | 
        
        | Term 
 
        | Anticholinergics and the elderly |  | Definition 
 
        | more sensitive to anticholinergics carefully monitor more confusion and disorientation may need lower doses |  | 
        |  | 
        
        | Term 
 
        | Antiparkinsonism drugs, elderly and hallucinations |  | Definition 
 
        | Elderly more prone to hallucinations with antipark drugs Especially with dopamine receptor agonists |  | 
        |  | 
        
        | Term 
 
        | dopinergics and tricyclcs |  | Definition 
 
        | increased risk of hyptertension and dyskinesia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increases effect of levodopa |  | 
        |  | 
        
        | Term 
 
        | levodopa and anticonvulsants |  | Definition 
 
        | decreased effect of levodopa |  | 
        |  | 
        
        | Term 
 
        | levodopa and the blood brain barrier |  | Definition 
 
        | levodopa only crosses in small amounts carbidopa helps more cross BB barrier |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increases risk of toxicity of both |  | 
        |  | 
        
        | Term 
 
        | COMT inhibitor and adrenergic drugs |  | Definition 
 
        | increases risk of cardiac symtoms |  | 
        |  | 
        
        | Term 
 
        | anticholinergic with amantadine |  | Definition 
 
        | increases anti-cholinergic effects |  | 
        |  | 
        
        | Term 
 
        | anticholinergic with digoxin |  | Definition 
 
        | increases serum digoxin levels |  | 
        |  | 
        
        | Term 
 
        | anticholinergic with haloperidol |  | Definition 
 
        | increases psychotic behavior |  | 
        |  | 
        
        | Term 
 
        | anticholinergic and phenothiazines |  | Definition 
 
        | increases anticholinergic effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
catechol-O-methyl transferaseAn enzyme involved in NT degradationFor parkinson's, prevents breakdown of dopamine |  | 
        |  | 
        
        | Term 
 
        | AMANTADINE What type of drug is it? |  | Definition 
 
        | A dopinergic drug used for Parkinson's and extrapyramidal syndromes |  | 
        |  | 
        
        | Term 
 
        | BROMOCRIPTINE What kind of drug and what used for? |  | Definition 
 
        | A dopinergic used for Parkinson's and female endocrine imbalances |  | 
        |  | 
        
        | Term 
 
        | RASAGILINE SELEGILINE What class of drugs are these? |  | Definition 
 
        | MAOI dopiminergics for Parkinson's |  | 
        |  | 
        
        | Term 
 
        | Signs of phenytoin toxicity |  | Definition 
 
        | slurred speech ataxia lethargy dizziness N/V |  | 
        |  | 
        
        | Term 
 
        | non-ergot dopamine receptor agonists and CNS depressants |  | Definition 
 
        | increased risk of CNS depression |  | 
        |  | 
        
        | Term 
 
        | non-ergot dopamine receptor agonists and levodopa |  | Definition 
 
        | increases effect of levodopa, increasing risk of hallucinations |  | 
        |  | 
        
        | Term 
 
        | non-ergot dopamine receptor agonists and ciprofloxacin |  | Definition 
 
        | increases effect of  non-ergot dopamine receptor agonists |  | 
        |  | 
        
        | Term 
 
        | non-ergot dopamine receptor agonists and cimetidine |  | Definition 
 
        | increases action of  non-ergot dopamine receptor agonists |  | 
        |  | 
        
        | Term 
 
        | non-ergot dopamine receptor agonists and verapamil |  | Definition 
 
        | increases the effect of non-ergot dopamine receptor agonists |  | 
        |  | 
        
        | Term 
 
        | non-ergot dopamine receptor agonists and quinidine |  | Definition 
 
        | increases effect of  non-ergot dopamine receptor agonists |  | 
        |  | 
        
        | Term 
 
        | non-ergot dopamine receptor agonists and estrogen |  | Definition 
 
        | increases effect of  non-ergot dopamine receptor agonists |  | 
        |  | 
        
        | Term 
 
        | non-ergot dopamine receptor agonists and phentiazines |  | Definition 
 
        | decreases the effect of  non-ergot dopamine receptor agonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An anticholinergic used for parkinson's |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An anticholinergic used for parkinson's |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An anticholinergic used for parkinson's |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An anticholinergic used for parkinson's |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non-ergot dopamine receptor agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non-ergot dopamine receptor agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non-ergot dopamine receptor agonist Used to contol on-off syndrome |  | 
        |  | 
        
        | Term 
 
        | How often is tolcapone monitored for toxicity? |  | Definition 
 
        | q 2 weeks first year q 8 weeks afterwards |  | 
        |  | 
        
        | Term 
 
        | What is apomorphine used for and what must it be administered with? |  | Definition 
 
        | For on-off phenom of levodopa in parkinson's Must be given with an anti-emetic |  | 
        |  | 
        
        | Term 
 
        | If a pt taking levodopa has chorieform movements, what is the nurse to do? |  | Definition 
 
        | Withhold and report immediately |  | 
        |  | 
        
        | Term 
 
        | what kind of drugs are entacapone and tolcapone? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | When pt should report antiparkinson drug adverse effects |  | Definition 
 
        | 
severe dry mouth inability to chew or swallow can’t urinatedepression, mood alterationssevere dizzinessrapid or irregular heartbeatab painunusual movements |  | 
        |  |